Cell Therapy-Global Market Status and Trend Report 2013-2023
Report Summary
Cell Therapy-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Cell Therapy industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Cell Therapy 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Cell Therapy worldwide, with company and product introduction, position in the Cell Therapy market
Market status and development trend of Cell Therapy by types and applications
Cost and profit status of Cell Therapy, and marketing status
Market growth drivers and challenges
The report segments the global Cell Therapy market as:
Global Cell Therapy Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Cell Therapy Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Nanotechnology
Natural Substances
Global Cell Therapy Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Scientific Research
Hospital
Other
Global Cell Therapy Market: Manufacturers Segment Analysis (Company and Product introduction, Cell Therapy Sales Volume, Revenue, Price and Gross Margin):
Dendreon
Mesoblast
Vericel
AlloCure
Amorcyte
Anterogen
Antibe Therapeutics
Astellas Pharma
Athersys
Avita Medical
AxoGen
Bellicum Pharmaceuticals
BioCardia
BIOCELLULAR THERAPIES
Biogen Idec
Bio-Tissue
BIOTIME
BioTissue Technologies
BrainStorm Cell Therapeutics
Bluebird Bio
Bone Therapeutics
Caladrius
Capricor Therapeutics
CellBioMed
Celgene
Cell Medica
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Cell Therapy-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Cell Therapy industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Cell Therapy 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Cell Therapy worldwide, with company and product introduction, position in the Cell Therapy market
Market status and development trend of Cell Therapy by types and applications
Cost and profit status of Cell Therapy, and marketing status
Market growth drivers and challenges
The report segments the global Cell Therapy market as:
Global Cell Therapy Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Cell Therapy Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Nanotechnology
Natural Substances
Global Cell Therapy Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Scientific Research
Hospital
Other
Global Cell Therapy Market: Manufacturers Segment Analysis (Company and Product introduction, Cell Therapy Sales Volume, Revenue, Price and Gross Margin):
Dendreon
Mesoblast
Vericel
AlloCure
Amorcyte
Anterogen
Antibe Therapeutics
Astellas Pharma
Athersys
Avita Medical
AxoGen
Bellicum Pharmaceuticals
BioCardia
BIOCELLULAR THERAPIES
Biogen Idec
Bio-Tissue
BIOTIME
BioTissue Technologies
BrainStorm Cell Therapeutics
Bluebird Bio
Bone Therapeutics
Caladrius
Capricor Therapeutics
CellBioMed
Celgene
Cell Medica
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF CELL THERAPY
1.1 Definition of Cell Therapy in This Report
1.2 Commercial Types of Cell Therapy
1.2.1 Nanotechnology
1.2.2 Natural Substances
1.3 Downstream Application of Cell Therapy
1.3.1 Scientific Research
1.3.2 Hospital
1.3.3 Other
1.4 Development History of Cell Therapy
1.5 Market Status and Trend of Cell Therapy 2013-2023
1.5.1 Global Cell Therapy Market Status and Trend 2013-2023
1.5.2 Regional Cell Therapy Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Cell Therapy 2013-2017
2.2 Sales Market of Cell Therapy by Regions
2.2.1 Sales Volume of Cell Therapy by Regions
2.2.2 Sales Value of Cell Therapy by Regions
2.3 Production Market of Cell Therapy by Regions
2.4 Global Market Forecast of Cell Therapy 2018-2023
2.4.1 Global Market Forecast of Cell Therapy 2018-2023
2.4.2 Market Forecast of Cell Therapy by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Cell Therapy by Types
3.2 Sales Value of Cell Therapy by Types
3.3 Market Forecast of Cell Therapy by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Cell Therapy by Downstream Industry
4.2 Global Market Forecast of Cell Therapy by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Cell Therapy Market Status by Countries
5.1.1 North America Cell Therapy Sales by Countries (2013-2017)
5.1.2 North America Cell Therapy Revenue by Countries (2013-2017)
5.1.3 United States Cell Therapy Market Status (2013-2017)
5.1.4 Canada Cell Therapy Market Status (2013-2017)
5.1.5 Mexico Cell Therapy Market Status (2013-2017)
5.2 North America Cell Therapy Market Status by Manufacturers
5.3 North America Cell Therapy Market Status by Type (2013-2017)
5.3.1 North America Cell Therapy Sales by Type (2013-2017)
5.3.2 North America Cell Therapy Revenue by Type (2013-2017)
5.4 North America Cell Therapy Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Cell Therapy Market Status by Countries
6.1.1 Europe Cell Therapy Sales by Countries (2013-2017)
6.1.2 Europe Cell Therapy Revenue by Countries (2013-2017)
6.1.3 Germany Cell Therapy Market Status (2013-2017)
6.1.4 UK Cell Therapy Market Status (2013-2017)
6.1.5 France Cell Therapy Market Status (2013-2017)
6.1.6 Italy Cell Therapy Market Status (2013-2017)
6.1.7 Russia Cell Therapy Market Status (2013-2017)
6.1.8 Spain Cell Therapy Market Status (2013-2017)
6.1.9 Benelux Cell Therapy Market Status (2013-2017)
6.2 Europe Cell Therapy Market Status by Manufacturers
6.3 Europe Cell Therapy Market Status by Type (2013-2017)
6.3.1 Europe Cell Therapy Sales by Type (2013-2017)
6.3.2 Europe Cell Therapy Revenue by Type (2013-2017)
6.4 Europe Cell Therapy Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Cell Therapy Market Status by Countries
7.1.1 Asia Pacific Cell Therapy Sales by Countries (2013-2017)
7.1.2 Asia Pacific Cell Therapy Revenue by Countries (2013-2017)
7.1.3 China Cell Therapy Market Status (2013-2017)
7.1.4 Japan Cell Therapy Market Status (2013-2017)
7.1.5 India Cell Therapy Market Status (2013-2017)
7.1.6 Southeast Asia Cell Therapy Market Status (2013-2017)
7.1.7 Australia Cell Therapy Market Status (2013-2017)
7.2 Asia Pacific Cell Therapy Market Status by Manufacturers
7.3 Asia Pacific Cell Therapy Market Status by Type (2013-2017)
7.3.1 Asia Pacific Cell Therapy Sales by Type (2013-2017)
7.3.2 Asia Pacific Cell Therapy Revenue by Type (2013-2017)
7.4 Asia Pacific Cell Therapy Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Cell Therapy Market Status by Countries
8.1.1 Latin America Cell Therapy Sales by Countries (2013-2017)
8.1.2 Latin America Cell Therapy Revenue by Countries (2013-2017)
8.1.3 Brazil Cell Therapy Market Status (2013-2017)
8.1.4 Argentina Cell Therapy Market Status (2013-2017)
8.1.5 Colombia Cell Therapy Market Status (2013-2017)
8.2 Latin America Cell Therapy Market Status by Manufacturers
8.3 Latin America Cell Therapy Market Status by Type (2013-2017)
8.3.1 Latin America Cell Therapy Sales by Type (2013-2017)
8.3.2 Latin America Cell Therapy Revenue by Type (2013-2017)
8.4 Latin America Cell Therapy Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Cell Therapy Market Status by Countries
9.1.1 Middle East and Africa Cell Therapy Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Cell Therapy Revenue by Countries (2013-2017)
9.1.3 Middle East Cell Therapy Market Status (2013-2017)
9.1.4 Africa Cell Therapy Market Status (2013-2017)
9.2 Middle East and Africa Cell Therapy Market Status by Manufacturers
9.3 Middle East and Africa Cell Therapy Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Cell Therapy Sales by Type (2013-2017)
9.3.2 Middle East and Africa Cell Therapy Revenue by Type (2013-2017)
9.4 Middle East and Africa Cell Therapy Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF CELL THERAPY
10.1 Global Economy Situation and Trend Overview
10.2 Cell Therapy Downstream Industry Situation and Trend Overview
CHAPTER 11 CELL THERAPY MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Cell Therapy by Major Manufacturers
11.2 Production Value of Cell Therapy by Major Manufacturers
11.3 Basic Information of Cell Therapy by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Cell Therapy Major Manufacturer
11.3.2 Employees and Revenue Level of Cell Therapy Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 CELL THERAPY MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Dendreon
12.1.1 Company profile
12.1.2 Representative Cell Therapy Product
12.1.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Dendreon
12.2 Mesoblast
12.2.1 Company profile
12.2.2 Representative Cell Therapy Product
12.2.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Mesoblast
12.3 Vericel
12.3.1 Company profile
12.3.2 Representative Cell Therapy Product
12.3.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Vericel
12.4 AlloCure
12.4.1 Company profile
12.4.2 Representative Cell Therapy Product
12.4.3 Cell Therapy Sales, Revenue, Price and Gross Margin of AlloCure
12.5 Amorcyte
12.5.1 Company profile
12.5.2 Representative Cell Therapy Product
12.5.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Amorcyte
12.6 Anterogen
12.6.1 Company profile
12.6.2 Representative Cell Therapy Product
12.6.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Anterogen
12.7 Antibe Therapeutics
12.7.1 Company profile
12.7.2 Representative Cell Therapy Product
12.7.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Antibe Therapeutics
12.8 Astellas Pharma
12.8.1 Company profile
12.8.2 Representative Cell Therapy Product
12.8.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Astellas Pharma
12.9 Athersys
12.9.1 Company profile
12.9.2 Representative Cell Therapy Product
12.9.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Athersys
12.10 Avita Medical
12.10.1 Company profile
12.10.2 Representative Cell Therapy Product
12.10.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Avita Medical
12.11 AxoGen
12.11.1 Company profile
12.11.2 Representative Cell Therapy Product
12.11.3 Cell Therapy Sales, Revenue, Price and Gross Margin of AxoGen
12.12 Bellicum Pharmaceuticals
12.12.1 Company profile
12.12.2 Representative Cell Therapy Product
12.12.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Bellicum Pharmaceuticals
12.13 BioCardia
12.13.1 Company profile
12.13.2 Representative Cell Therapy Product
12.13.3 Cell Therapy Sales, Revenue, Price and Gross Margin of BioCardia
12.14 BIOCELLULAR THERAPIES
12.14.1 Company profile
12.14.2 Representative Cell Therapy Product
12.14.3 Cell Therapy Sales, Revenue, Price and Gross Margin of BIOCELLULAR THERAPIES
12.15 Biogen Idec
12.15.1 Company profile
12.15.2 Representative Cell Therapy Product
12.15.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Biogen Idec
12.16 Bio-Tissue
12.17 BIOTIME
12.18 BioTissue Technologies
12.19 BrainStorm Cell Therapeutics
12.20 Bluebird Bio
12.21 Bone Therapeutics
12.22 Caladrius
12.23 Capricor Therapeutics
12.24 CellBioMed
12.25 Celgene
12.26 Cell Medica
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF CELL THERAPY
13.1 Industry Chain of Cell Therapy
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF CELL THERAPY
14.1 Cost Structure Analysis of Cell Therapy
14.2 Raw Materials Cost Analysis of Cell Therapy
14.3 Labor Cost Analysis of Cell Therapy
14.4 Manufacturing Expenses Analysis of Cell Therapy
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Cell Therapy in This Report
1.2 Commercial Types of Cell Therapy
1.2.1 Nanotechnology
1.2.2 Natural Substances
1.3 Downstream Application of Cell Therapy
1.3.1 Scientific Research
1.3.2 Hospital
1.3.3 Other
1.4 Development History of Cell Therapy
1.5 Market Status and Trend of Cell Therapy 2013-2023
1.5.1 Global Cell Therapy Market Status and Trend 2013-2023
1.5.2 Regional Cell Therapy Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Cell Therapy 2013-2017
2.2 Sales Market of Cell Therapy by Regions
2.2.1 Sales Volume of Cell Therapy by Regions
2.2.2 Sales Value of Cell Therapy by Regions
2.3 Production Market of Cell Therapy by Regions
2.4 Global Market Forecast of Cell Therapy 2018-2023
2.4.1 Global Market Forecast of Cell Therapy 2018-2023
2.4.2 Market Forecast of Cell Therapy by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Cell Therapy by Types
3.2 Sales Value of Cell Therapy by Types
3.3 Market Forecast of Cell Therapy by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Cell Therapy by Downstream Industry
4.2 Global Market Forecast of Cell Therapy by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Cell Therapy Market Status by Countries
5.1.1 North America Cell Therapy Sales by Countries (2013-2017)
5.1.2 North America Cell Therapy Revenue by Countries (2013-2017)
5.1.3 United States Cell Therapy Market Status (2013-2017)
5.1.4 Canada Cell Therapy Market Status (2013-2017)
5.1.5 Mexico Cell Therapy Market Status (2013-2017)
5.2 North America Cell Therapy Market Status by Manufacturers
5.3 North America Cell Therapy Market Status by Type (2013-2017)
5.3.1 North America Cell Therapy Sales by Type (2013-2017)
5.3.2 North America Cell Therapy Revenue by Type (2013-2017)
5.4 North America Cell Therapy Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Cell Therapy Market Status by Countries
6.1.1 Europe Cell Therapy Sales by Countries (2013-2017)
6.1.2 Europe Cell Therapy Revenue by Countries (2013-2017)
6.1.3 Germany Cell Therapy Market Status (2013-2017)
6.1.4 UK Cell Therapy Market Status (2013-2017)
6.1.5 France Cell Therapy Market Status (2013-2017)
6.1.6 Italy Cell Therapy Market Status (2013-2017)
6.1.7 Russia Cell Therapy Market Status (2013-2017)
6.1.8 Spain Cell Therapy Market Status (2013-2017)
6.1.9 Benelux Cell Therapy Market Status (2013-2017)
6.2 Europe Cell Therapy Market Status by Manufacturers
6.3 Europe Cell Therapy Market Status by Type (2013-2017)
6.3.1 Europe Cell Therapy Sales by Type (2013-2017)
6.3.2 Europe Cell Therapy Revenue by Type (2013-2017)
6.4 Europe Cell Therapy Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Cell Therapy Market Status by Countries
7.1.1 Asia Pacific Cell Therapy Sales by Countries (2013-2017)
7.1.2 Asia Pacific Cell Therapy Revenue by Countries (2013-2017)
7.1.3 China Cell Therapy Market Status (2013-2017)
7.1.4 Japan Cell Therapy Market Status (2013-2017)
7.1.5 India Cell Therapy Market Status (2013-2017)
7.1.6 Southeast Asia Cell Therapy Market Status (2013-2017)
7.1.7 Australia Cell Therapy Market Status (2013-2017)
7.2 Asia Pacific Cell Therapy Market Status by Manufacturers
7.3 Asia Pacific Cell Therapy Market Status by Type (2013-2017)
7.3.1 Asia Pacific Cell Therapy Sales by Type (2013-2017)
7.3.2 Asia Pacific Cell Therapy Revenue by Type (2013-2017)
7.4 Asia Pacific Cell Therapy Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Cell Therapy Market Status by Countries
8.1.1 Latin America Cell Therapy Sales by Countries (2013-2017)
8.1.2 Latin America Cell Therapy Revenue by Countries (2013-2017)
8.1.3 Brazil Cell Therapy Market Status (2013-2017)
8.1.4 Argentina Cell Therapy Market Status (2013-2017)
8.1.5 Colombia Cell Therapy Market Status (2013-2017)
8.2 Latin America Cell Therapy Market Status by Manufacturers
8.3 Latin America Cell Therapy Market Status by Type (2013-2017)
8.3.1 Latin America Cell Therapy Sales by Type (2013-2017)
8.3.2 Latin America Cell Therapy Revenue by Type (2013-2017)
8.4 Latin America Cell Therapy Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Cell Therapy Market Status by Countries
9.1.1 Middle East and Africa Cell Therapy Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Cell Therapy Revenue by Countries (2013-2017)
9.1.3 Middle East Cell Therapy Market Status (2013-2017)
9.1.4 Africa Cell Therapy Market Status (2013-2017)
9.2 Middle East and Africa Cell Therapy Market Status by Manufacturers
9.3 Middle East and Africa Cell Therapy Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Cell Therapy Sales by Type (2013-2017)
9.3.2 Middle East and Africa Cell Therapy Revenue by Type (2013-2017)
9.4 Middle East and Africa Cell Therapy Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF CELL THERAPY
10.1 Global Economy Situation and Trend Overview
10.2 Cell Therapy Downstream Industry Situation and Trend Overview
CHAPTER 11 CELL THERAPY MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Cell Therapy by Major Manufacturers
11.2 Production Value of Cell Therapy by Major Manufacturers
11.3 Basic Information of Cell Therapy by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Cell Therapy Major Manufacturer
11.3.2 Employees and Revenue Level of Cell Therapy Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 CELL THERAPY MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Dendreon
12.1.1 Company profile
12.1.2 Representative Cell Therapy Product
12.1.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Dendreon
12.2 Mesoblast
12.2.1 Company profile
12.2.2 Representative Cell Therapy Product
12.2.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Mesoblast
12.3 Vericel
12.3.1 Company profile
12.3.2 Representative Cell Therapy Product
12.3.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Vericel
12.4 AlloCure
12.4.1 Company profile
12.4.2 Representative Cell Therapy Product
12.4.3 Cell Therapy Sales, Revenue, Price and Gross Margin of AlloCure
12.5 Amorcyte
12.5.1 Company profile
12.5.2 Representative Cell Therapy Product
12.5.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Amorcyte
12.6 Anterogen
12.6.1 Company profile
12.6.2 Representative Cell Therapy Product
12.6.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Anterogen
12.7 Antibe Therapeutics
12.7.1 Company profile
12.7.2 Representative Cell Therapy Product
12.7.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Antibe Therapeutics
12.8 Astellas Pharma
12.8.1 Company profile
12.8.2 Representative Cell Therapy Product
12.8.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Astellas Pharma
12.9 Athersys
12.9.1 Company profile
12.9.2 Representative Cell Therapy Product
12.9.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Athersys
12.10 Avita Medical
12.10.1 Company profile
12.10.2 Representative Cell Therapy Product
12.10.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Avita Medical
12.11 AxoGen
12.11.1 Company profile
12.11.2 Representative Cell Therapy Product
12.11.3 Cell Therapy Sales, Revenue, Price and Gross Margin of AxoGen
12.12 Bellicum Pharmaceuticals
12.12.1 Company profile
12.12.2 Representative Cell Therapy Product
12.12.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Bellicum Pharmaceuticals
12.13 BioCardia
12.13.1 Company profile
12.13.2 Representative Cell Therapy Product
12.13.3 Cell Therapy Sales, Revenue, Price and Gross Margin of BioCardia
12.14 BIOCELLULAR THERAPIES
12.14.1 Company profile
12.14.2 Representative Cell Therapy Product
12.14.3 Cell Therapy Sales, Revenue, Price and Gross Margin of BIOCELLULAR THERAPIES
12.15 Biogen Idec
12.15.1 Company profile
12.15.2 Representative Cell Therapy Product
12.15.3 Cell Therapy Sales, Revenue, Price and Gross Margin of Biogen Idec
12.16 Bio-Tissue
12.17 BIOTIME
12.18 BioTissue Technologies
12.19 BrainStorm Cell Therapeutics
12.20 Bluebird Bio
12.21 Bone Therapeutics
12.22 Caladrius
12.23 Capricor Therapeutics
12.24 CellBioMed
12.25 Celgene
12.26 Cell Medica
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF CELL THERAPY
13.1 Industry Chain of Cell Therapy
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF CELL THERAPY
14.1 Cost Structure Analysis of Cell Therapy
14.2 Raw Materials Cost Analysis of Cell Therapy
14.3 Labor Cost Analysis of Cell Therapy
14.4 Manufacturing Expenses Analysis of Cell Therapy
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
